Internal medicine journal
-
Internal medicine journal · Aug 2024
Observational StudyCOVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.
Amid concerns about severe COVID-19 in patients with autoimmune rheumatic disease (AIRD) during the outbreak, it is crucial to explore behavioural changes, whether healthy or unhealthy, arising from this patient population in response to the changing healthcare environment. ⋯ The COVID-19 pandemic has resulted in behaviour changes among patients with AIRD. Despite the perceived risk, most of these patients continue to adhere to their prescribed medication regimens, especially maintaining the dosage of traditional immunosuppressive agents.
-
Internal medicine journal · Aug 2024
Omalizumab for management of hypersensitivity reactions to anticancer drugs.
Hypersensitivity reactions to anticancer drugs include treatment-limiting toxicity. Standard drug desensitisation offers temporary tolerance and hence requires repetition. ⋯ Seven of the eight patients in the current study successfully resumed the desired anticancer drug regimen without standard desensitisation. No safety issues from omalizumab were observed.